Published in J Stroke on September 30, 2014
Primary stent retrieval for acute intracranial large artery occlusion due to atherosclerotic disease. J Stroke (2015) 0.89
Imaging Predictors for Atherosclerosis-Related Intracranial Large Artery Occlusions in Acute Anterior Circulation Stroke. J Stroke (2016) 0.78
Differential impact of serum total bilirubin level on cerebral atherosclerosis and cerebral small vessel disease. PLoS One (2017) 0.75
Visceral adiposity index, lipid accumulation product and intracranial atherosclerotic stenosis in middle-aged and elderly Chinese. Sci Rep (2017) 0.75
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 12.76
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med (2013) 8.76
Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol (1969) 6.86
Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med (2012) 5.69
Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care (2005) 5.39
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet (2013) 4.57
An evidence-based causative classification system for acute ischemic stroke. Ann Neurol (2005) 3.09
Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. Lancet Neurol (2010) 2.99
Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol (2010) 2.97
Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. Neurology (1989) 2.74
Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology (2005) 2.45
Basilar artery branch occlusion: a cause of pontine infarction. Neurology (1971) 2.31
Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab (1999) 2.25
Race, sex and occlusive cerebrovascular disease: a review. Stroke (1986) 2.05
Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke (2007) 2.00
Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study. Lancet Neurol (2008) 1.98
Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patients. AJNR Am J Neuroradiol (2008) 1.93
In vivo high-resolution MR imaging of symptomatic and asymptomatic middle cerebral artery atherosclerotic stenosis. Atherosclerosis (2010) 1.90
Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease: early diffusion-weighted imaging study. Stroke (2005) 1.81
Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg (1997) 1.79
Racial and ethnic disparities in cardiovascular risk factors among stroke survivors: United States 1999 to 2001. Stroke (2004) 1.66
Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke (2001) 1.66
Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol (2002) 1.64
New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis (2009) 1.63
Is 15 mm size criterion for lacunar infarction still valid? A study on strictly subcortical middle cerebral artery territory infarction using diffusion-weighted MRI. Cerebrovasc Dis (2006) 1.63
Outcome of patients with ≥70% symptomatic intracranial stenosis after Wingspan stenting. Stroke (2011) 1.62
CVD risk factors and ethnicity--a homogeneous relationship? Atheroscler Suppl (2006) 1.50
Role of balloon-expandable stents in intracranial atherosclerotic disease in a series of 182 patients. Stroke (2013) 1.44
Progression of unilateral moyamoya disease: A clinical series. Cerebrovasc Dis (2006) 1.40
Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol. Diabetes Obes Metab (2003) 1.29
High resolution wall and lumen MRI of the middle cerebral arteries at 3 tesla. Cerebrovasc Dis (2009) 1.24
Risk factors and stroke mechanisms in atherosclerotic stroke: intracranial compared with extracranial and anterior compared with posterior circulation disease. Stroke (2012) 1.23
Middle cerebral artery stenosis is a major clinical determinant in striatocapsular small, deep infarction. Arch Neurol (2002) 1.23
Angioplasty and stenting of atherosclerotic middle cerebral arteries with Wingspan: evaluation of clinical outcome, restenosis, and procedure outcome. AJNR Am J Neuroradiol (2011) 1.23
Eccentric narrowing and enhancement of symptomatic middle cerebral artery stenoses in patients with recent ischemic stroke. Arch Neurol (2011) 1.20
Atherosclerotic disease of the middle cerebral artery. Stroke (1987) 1.18
Nature of occlusions of the middle cerebral artery. Neurology (1970) 1.18
A new subtype classification of ischemic stroke based on treatment and etiologic mechanism. Eur Neurol (2006) 1.16
Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. Cerebrovasc Dis (2009) 1.13
Cervicocranial arterial dissection: experience of 73 patients in a single center. Surg Neurol (2009) 1.08
Cilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction. J Stroke Cerebrovasc Dis (2013) 1.05
Prevalence and risk factors of middle cerebral artery stenosis in asymptomatic residents in Rongqi County, Guangdong. Cerebrovasc Dis (2007) 1.05
Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke (2011) 1.03
In vivo middle cerebral artery plaque imaging by high-resolution MRI. Neurology (2006) 1.03
Intracranial atherosclerosis: current understanding and perspectives. J Stroke (2014) 1.00
A single-center study of Wingspan stents for symptomatic atherosclerotic stenosis of the middle cerebral artery. J Clin Neurosci (2012) 0.99
Ischemic stroke subtype classification: an asian viewpoint. J Stroke (2014) 0.99
Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene. J Stroke (2014) 0.98
Chinese ischemic stroke subclassification. Front Neurol (2011) 0.98
Single subcortical infarction and atherosclerotic plaques in the middle cerebral artery: high-resolution magnetic resonance imaging findings. Stroke (2013) 0.96
Biological signatures of asymptomatic extra- and intracranial atherosclerosis: the Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) study. Stroke (2012) 0.95
Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial. Cerebrovasc Dis (2011) 0.94
A Comparison of Stent Implant versus Medical Treatment for Severe Symptomatic Intracranial Stenosis: A Controlled Clinical Trial. Cerebrovasc Dis Extra (2012) 0.92
An explanation for variations in distribution of stroke and arteriosclerotic heart disease among populations and racial groups. Am J Epidemiol (1971) 0.91
MRI findings of small subcortical "lacunar-like" infarction resulting from large vessel disease. J Neurol (2000) 0.89
Cerebral atherosclerosis in Negroes and Caucasians. Atherosclerosis (1973) 0.88
Frequency and clinical correlates of occlusive lesions of cerebral arteries in Japanese patients without stroke. Evaluation by MR angiography. Cerebrovasc Dis (1998) 0.88
Branch occlusive disease: clinical and magnetic resonance angiography findings. Neurology (2012) 0.87
Single subcortical infarction associated with parental arterial disease: important yet neglected sub-type of atherothrombotic stroke. Int J Stroke (2012) 0.87
[Safety and short-term results of stent-assisted angioplasty for the treatment of intracranial arterial stenosis]. Zhonghua Wai Ke Za Zhi (2004) 0.86
Development of cerebral atherosclerosis in various age groups. Neurology (1959) 0.86
Metabolic syndrome is more associated with intracranial atherosclerosis than extracranial atherosclerosis. Eur J Neurol (2007) 0.85
MR angiography and imaging for the evaluation of middle cerebral artery atherosclerotic disease. AJNR Am J Neuroradiol (2011) 0.84
Risk factors and clinical outcomes associated with intracranial and extracranial atherosclerotic stenosis acute ischemic stroke. J Stroke Cerebrovasc Dis (2013) 0.83
Reperfusion injury on magnetic resonance imaging after carotid revascularization. Stroke (2013) 0.83
Angioplasty and stenting for intracranial atherosclerotic stenosis: position statement of the Hong Kong Society of Interventional and Therapeutic Neuroradiology. Hong Kong Med J (2013) 0.83
Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis: data from a diverse race-ethnic group. J Neurol Sci (2009) 0.83
Adult cervicocerebral artery dissection: a single-center study of 301 Finnish patients. Eur J Neurol (2009) 0.82
Classic risk factors for atherosclerosis are not major determinants for location of extracranial or intracranial cerebral atherosclerosis. Neuroepidemiology (2009) 0.82
Intracranial atheromatous disease treatment with the Wingspan stent system: evaluation of clinical, procedural outcome and restenosis rate in a single-center series of 21 consecutive patients with acute and mid-term results. Clin Neurol Neurosurg (2012) 0.81
Subtyping of ischemic stroke based on vascular imaging: analysis of 1,167 acute, consecutive patients. J Clin Neurol (2006) 0.81
Usefulness of stent implantation for treatment of intracranial atherosclerotic stenoses. Neurointervention (2012) 0.80
Small subcortical infarct and intracranial large artery disease in Chinese. J Neurol Sci (2003) 0.78
Two different morphologies of chronic unilateral middle cerebral artery occlusion: evaluation using high-resolution MRI. J Neuroimaging (2013) 0.77
Clinical features and outcome in North American adults with idiopathic basal arterial occlusive disease without moyamoya collaterals. Neurosurgery (2010) 0.76
Cilostazol: a drug particularly effective for Asians? Int J Stroke (2011) 0.76
Diagnostic and Therapeutic Strategies for Acute Intracranial Atherosclerosis-related Occlusions. J Stroke (2017) 0.87
Vascular tortuosity may be related to intracranial artery atherosclerosis. Int J Stroke (2015) 0.77
Impact of Provoking Risk Factors on the Prognosis of Cerebral Venous Thrombosis in Korean Patients. J Stroke (2016) 0.75
Hemodynamic Tandem Intracranial Lesions on Magnetic Resonance Angiography in Patients Undergoing Carotid Endarterectomy. J Am Heart Assoc (2016) 0.75
Ischemic stroke on optimal anticoagulation with novel-oral anticoagulants compared with warfarin. Int J Stroke (2015) 0.75
The effect of cilostazol on carotid intima-media thickness progression in patients with symptomatic intracranial atherosclerotic stenosis. J Stroke Cerebrovasc Dis (2013) 0.75
Apathy after subarachnoid haemorrhage: A systematic review. J Psychosom Res (2022) 0.75